9-21367809-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006900.4(IFNA13):c.202G>T(p.Asp68Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000314 in 1,592,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006900.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNA13 | NM_006900.4 | c.202G>T | p.Asp68Tyr | missense_variant | 1/1 | ENST00000610660.2 | NP_008831.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNA13 | ENST00000610660.2 | c.202G>T | p.Asp68Tyr | missense_variant | 1/1 | NM_006900.4 | ENSP00000480467 | P4 | ||
IFNA13 | ENST00000449498.2 | c.199G>T | p.Asp67Tyr | missense_variant | 1/1 | ENSP00000394494 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000700 AC: 10AN: 142916Hom.: 0 Cov.: 24
GnomAD3 exomes AF: 0.00000864 AC: 2AN: 231392Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 126658
GnomAD4 exome AF: 0.0000276 AC: 40AN: 1449328Hom.: 0 Cov.: 31 AF XY: 0.0000264 AC XY: 19AN XY: 719760
GnomAD4 genome AF: 0.0000700 AC: 10AN: 142916Hom.: 0 Cov.: 24 AF XY: 0.0000435 AC XY: 3AN XY: 69014
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.202G>T (p.D68Y) alteration is located in exon 1 (coding exon 1) of the IFNA13 gene. This alteration results from a G to T substitution at nucleotide position 202, causing the aspartic acid (D) at amino acid position 68 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at